PER 0.00% 10.0¢ percheron therapeutics limited

Sarepta FDA Hearing, page-51

  1. 4,361 Posts.
    lightbulb Created with Sketch. 2034
    https://endpts.com/fda-adcomm-backs-accelerated-approval-of-sareptas-duchenne-gene-therapy-in-close-vote/
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.